Cephalon Inc., founded in 1987 by Frank Baldino Jr., Ph.D., is an international biopharmaceutical speciality company dedicated to the discovery, development and marketing of innovative products in the oncology, pain, central nervous system and inflammatory disease areas.
At Cephalon, 3000 people worldwide are devoted to delivering new therapies to address unmet medical needs. With its drug delivery technologies and its research programmes, Cephalon is committed to improving patients’ lives.